FDA document lays out issues undermining approval of AstraZeneca's ZS Pharma drug

19th April 2017 Uncategorised 0

FDA document lays out issues undermining approval of AstraZeneca’s ZS Pharma drug
epalmer
Wed, 04/19/2017 – 15:34




More: FDA document lays out issues undermining approval of AstraZeneca's ZS Pharma drug
Source: fierce